Biocons Pegfilgrastim biosimilar sees competition in US and Europe

Coherus BioSciences received approval in US and Europe for its drug Udenyca (pegfilgrastim). This brings competition in Biocon/Mylan's Fulphila biosimilar.

from India Infoline News Service https://ift.tt/2P7oNVn